Welcome to our dedicated page for SOMNIGROUP INTERNATIONAL SEC filings (Ticker: SGI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Somnigroup International Inc. filings document regulatory disclosures for a NYSE-listed bedding company with common stock trading under SGI. Form 8-K reports cover operating and financial results, financial guidance, quarterly cash dividends, Regulation FD investor presentations, and other material-event disclosures tied to its omnichannel bedding platform.
Proxy materials describe board and shareholder voting matters, executive compensation, equity awards and governance practices. Company disclosures also identify business segments such as Mattress Firm, Tempur Sealy North America and Tempur Sealy International, along with capital-structure information for its common stock.
Somnigroup International Inc. reported strong first quarter 2026 results, with net sales of $1.8 billion, up 12.3% from $1.60 billion a year earlier. Net income swung to $104.2 million from a $33.1 million loss, and diluted EPS reached $0.49 versus $(0.17).
Adjusted net income was $124.5 million and adjusted EPS rose 20.4% to $0.59. Operating cash flow hit a record $246.5 million. The company ended the quarter with $4.6 billion of total debt and a consolidated indebtedness less netted cash to adjusted EBITDA ratio of 3.07x.
Management reaffirmed 2026 guidance, targeting adjusted EPS of $3.00–$3.40, about 19% above 2025 at the midpoint, and highlighted benefits from the Mattress Firm acquisition. Somnigroup also referenced a proposed all‑stock acquisition of Leggett & Platt valued at approximately $2.5 billion and declared a $0.17 per‑share quarterly dividend payable June 4, 2026.
Vanguard Capital Management reported beneficial ownership of 10,663,415 shares of Somnigroup International Inc Common Stock, representing 5.06% of the class as of 03/31/2026. The filing shows sole power to vote 1,585,160 shares and sole dispositive power over 10,663,415 shares. The filing is a Schedule 13G disclosure filed under passive/beneficial owner reporting and was signed on 04/30/2026.
Somnigroup International Inc. agreed to acquire Leggett & Platt, Incorporated in an all‑stock merger, with Leggett & Platt becoming a wholly owned subsidiary. Each share of LEG common stock will be converted into the right to receive 0.1455 shares of Somnigroup common stock, plus cash in lieu of fractional shares.
The deal has unanimous board approval and is subject to Leggett & Platt stockholder approval, antitrust and foreign investment clearances, effectiveness of a Form S‑4 registration statement, New York Stock Exchange listing of the new Somnigroup shares, and absence of specified material adverse events. The agreement includes mutual termination rights, an End Date of January 13, 2027 with up to three extensions, a $64 million termination fee payable by Leggett & Platt in certain circumstances, and an $80 million termination fee payable by Somnigroup if required approvals are not obtained. Equity awards for Leggett & Platt employees will generally convert into Somnigroup awards based on the same 0.1455 exchange ratio, with performance stock units for open performance periods deemed earned at 200% of target.
Somnigroup International Inc. is acquiring Leggett & Platt in an all-stock transaction valued at about $2.5 billion. Leggett & Platt shareholders will receive 0.1455 Somnigroup shares for each of their shares and are expected to own roughly 9% of the combined company on a fully diluted basis.
The deal, unanimously approved by both boards, is targeted to close by year-end 2026, subject to Leggett & Platt shareholder and regulatory approvals. Management expects the combination to be accretive to adjusted EPS before synergies in the first year and to reduce Somnigroup’s net financial leverage, supported by anticipated cost synergies.
Together, after eliminating intercompany sales, the companies generated 2025 net sales of about $11.2 billion, approximately $1.7 billion of adjusted EBITDA, and $1.1 billion of operating cash flow. The combined business is expected to run 175 manufacturing facilities in 36 countries with a workforce of more than 36,000, deepening Somnigroup’s vertical integration in bedding while adding diversified non-bedding revenue streams.
Somnigroup International Inc. is soliciting proxies for its 2026 virtual annual stockholder meeting on May 13, 2026, asking investors to elect eight directors, ratify Ernst & Young LLP as auditor, approve executive pay on an advisory basis, and amend its charter to increase authorized common shares from 500,000,000 to 1,000,000,000. As of March 16, 2026, 210,340,624 shares of common stock were outstanding and entitled to one vote each. The Board recommends voting “FOR” all four proposals and highlights its sustainability framework, board independence, risk oversight, and governance practices, including majority voting for directors and proxy access for stockholders.
Somnigroup International Inc Schedule 13G/A: The Vanguard Group filed an amendment reporting zero beneficial ownership of Somnigroup International Inc common stock after an internal realignment.
The amendment describes a disaggregation under SEC Release No. 34-39538 (January 12, 1998), stating certain Vanguard subsidiaries or business divisions will report ownership separately. The filing is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Somnigroup International Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held virtually on May 13, 2026. The meeting asks shareholders to elect eight directors, ratify Ernst & Young LLP as auditors, approve an advisory Say-on-Pay, and approve an amendment to increase authorized common shares to 1,000,000,000.
The record date for voting is March 16, 2026, when 210,340,624 shares outstanding were recorded. The Board recommends a "FOR" vote on all four proposals and provides voting instructions and a 16-digit control number for virtual participation.
Somnigroup International Inc. is hosting an Investor Day on March 4, 2026, featuring executive presentations on its strategic vision, growth initiatives across business units, the building blocks for multi-year financial targets, and its go-forward capital allocation strategy.
The event begins at 8:00 a.m. ET and will be streamed live via the company’s Investor Relations website, with a replay and presentation materials available online after the event. Attendance in person is by invitation only, and the information described is furnished as a Regulation FD disclosure rather than filed under the Exchange Act.
Somnigroup International Inc. reported that EVP Global Business Strategy David Montgomery received a grant of 9,015 performance restricted stock units at no cash cost. These units can pay out from 0% to 300% of the target based on adjusted EPS, adjusted EBITDA and strategic initiatives results.
The compensation committee set the final payout on February 26, 2026, resulting in the 9,015 performance shares reported. The PRSUs are scheduled to vest in roughly three equal installments on January 4, 2027, 2028 and 2029, and each unit converts into one share of common stock upon settlement.
Somnigroup International Inc. reported that Steven H. Rusing, President & CEO Mattress Firm, received a grant of 13,975 performance restricted stock units that convert into common stock on a one-for-one basis at no purchase price.
The grant relates to a target number of performance shares awarded on January 3, 2025, with the final payout from 0 to 300% of target based on adjusted EPS, adjusted EBITDA and qualitative Strategic Initiatives performance. The board committee determined the payout on February 26, 2026, resulting in the 13,975 units, which vest in roughly three equal installments on January 4, 2027, 2028 and 2029.